Most Recent
Investors in Till Payments have won discovery for a possible suit over $43 million in alleged losses suffered after it was sold for just $47 million following a $200 million capital raise, with a judge rejecting arguments that the bid amounted to a royal commission.
US biotech company Regeneron Pharmaceuticals has sued Sandoz, claiming it is threatening to infringe the patent for its Eylea biologic, used to treat macular degeneration and diabetic macular oedema.
Construction PRO
Fund manager Realside and other leaseholders have launched proceedings against M3Property and a valuer, alleging tenants of Rundle Mall in Adelaide have been overcharged for rent since 2006 as a result of consistently flawed valuations.
Derrimut Health and Fitness has challenged the Australian Taxation Office's rejection of its bid to pay a $14.6 million tax debt in installments.
ASIC has filed action against Delta Electricity, owner of the Vales Point coal-fired power station in NSW, alleging “deliberate and calculated” manipulation in the market for electricity futures contracts.
The corporate regulator has taken a provider of small loans to court after it allegedly monitored and removed funds from consumers’ bank accounts without their knowledge.
The University of Newcastle has been hit with a class action alleging students were misled into studying an engineering degree that lacked professional accreditation and left them unable to apply for employment.
Construction PRO
In a first, the federal government has filed proceedings against a foreign investor and its former associate for alleged non-compliance with orders to divest their interests in rare minerals miner Northern Minerals.
The competition watchdog has brought proceedings accusing Australian Gas Networks of greenwashing by running ads containing unqualified statements that renewable gas will be available to households within a generation.
The Therapeutic Goods Administration has dragged Mamamia and News Corp-owned Body + Soul magazine to Federal Court over alleged unlawful medicinal cannabis advertising.